Florence, Italy - March 23, 2017 Bess Dawson-Hughes, Professor of Medicine and Director of the Bone Metabolism Laboratory of the Jean Mayer USDA Human Nutrition Research Center on Ageing at Tufts University, Boston USA, has been awarded the 2017 International Osteoporosis Foundation (IOF) Medal of Achievement.
Presented today at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, the IOF Medal of Achievement honours an individual researcher who has significantly advanced the field of osteoporosis through original and outstanding scientific contributions. The award underlines important aspects of IOF's mission - to increase understanding and awareness of osteoporosis and to promote medical innovation and improved care.
Professor Cyrus Cooper, Chair of the IOF Committee of Scientific Advisors, stated: "It is an honour to present this award to Professor Bess Dawson-Hughes, an internationally recognized leader in the bone field whose extensive body of research has led to greater understanding of the role of nutrition in age-related bone and muscle loss. I'd also like to pay tribute to Bess' longstanding commitment to international education and advocacy, which has contributed substantially to awareness of bone nutrition among health professionals and the public alike. Finally, she has served our Foundation for over a decade in the demanding role of General Secretary, contributing greatly to the growth and success of the Foundation over this time."
Professor Dawson-Hughes is acknowledged as a highly cited researcher who has published more 450 peer-reviewed journal articles, book chapters and reviews. She is the Founding Director of the Center for the Advancement of Science in Space (CASIS) that develops and oversees research on the International Space Station. She is on the Editorial Boards of Bone, Osteoporosis International and Calcified Tissue International; Associate Editor of the Journal of Bone and Mineral Research (1995-2003), Principle Investigator of the NIH Osteoporosis and Related Bone Disease National Resource Center, Washington, D.C (2000-2003), General Secretary of the International Osteoporosis Foundation, Advisory Council of NIAMS (Oct. 2000-2004), and Past President and Trustee of the National Osteoporosis Foundation (USA).
Among her many awards, Professor Dawson-Hughes has received the Bolton L. Corson Medal for Research from the Benjamin Franklin Institute (1995), IOF President's Award (2012), HNRCA Award for the most highly cited peer-reviewed Manuscript, NOF Lawrence G. Raisz Memorial Lecture Award (2014), Thomson Reuters Highly cited Scientist (2014) and the International Institute for Nutrition and Bone Health Research Award (2015).
World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO Florence 2017):
Held jointly by IOF and ESCEO, the Congress takes place in Florence, Italy, from March 23-26, 2017. WCO-IOF-ESCEO is the world's largest annual forum for the presentation of clinical research and new advances in the prevention and management of bone, muscle and joint disorders, including sarcopenia and frailty. Congress abstracts will be published in Osteoporosis International, Volume 28, Supplement 1, March 2017. Congress abstracts will be published in Osteoporosis International, Volume 28, Supplement 1, March 2017. For complete information visit http://www.
The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers as well as 237 patient, medical and research societies in 99 locations, work together to make fracture prevention and healthy mobility a worldwide heath care priority. http://www.
The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. http://www.